Sun Life Financial Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SUNFF research report →
Price Chart
About the company
Sun Life Financial Inc. is a venerable financial services enterprise that delivers a comprehensive suite of insurance, wealth management, and asset management solutions to a diverse global clientele, encompassing both individuals and corporate entities. Its extensive insurance portfolio features term and permanent life coverage, alongside personal health, dental, critical illness, long-term care, and disability protection.
- CEO
- Kevin David Strain
- IPO
- 2019
- Employees
- 32,151
- HQ
- Toronto, ON, CA
Get TickerSpark's AI analysis on SUNFF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $6.56B
- P/E
- 19.13
- Fwd P/E
- 1.48
- PEG
- 10.08
- P/S
- 1.78
- P/B
- 2.12
- EV/EBITDA
- 11.67
- Div Yield
- 3.66%
- Gross Margin
- 45.99%
- Op Margin
- 13.68%
- Net Margin
- 10.35%
- ROE
- 12.66%
- ROIC
- 0.79%
Latest fiscal year · YoY change
- Revenue
- $42.17B+14.6%
- Gross Profit
- $42.17B+14.6%
- Op Income
- $4.80B
- Net Income
- $3.75B+18.1%
- EPS
- $6.16+17.1%
- OCF Growth
- +10.5%
- FCF Growth
- +11.1%
- 52W High
- $11.82
- 52W Low
- $11.02
- 50D MA
- $11.82
- 200D MA
- $11.82
- Beta
- 0.82
- RSI (14)
- 100
- Avg Volume
- 278
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Sun Life posted solid Q3 2026 results with double-digit underlying EPS growth, strong capital, and broad-based business momentum, though U.S. disability and dental remain key headwinds.· November 5, 2026
- Underlying EPS rose 10% to $2.05, with underlying net income up to $1.15 billion and ROE at 19%.
- Reported net income fell to $785 million from $1.1 billion a year ago, mainly due to market-related impacts plus GreenOak/Bell integration and restructuring costs.
- Canada, Asia, U.S. Stop Loss and GreenOak were the main growth drivers; insurance sales rose 12% and Canada wealth sales rose 21%.
- MFS still faced heavy retail outflows, with gross flows of USD 25.5 billion and net outflows of USD 26.9 billion, though ETF and fixed-income flows improved.
- Management raised the quarterly dividend by $0.04 to $1 per share and reiterated confidence in its medium-term ROE and EPS targets.
Underlying net income was $1.146 billion, up 9% from the prior year, and underlying EPS was $2.05, up 10%. Underlying ROE was 19%. Reported net income was $785 million versus $1.1 billion a year ago. Canada underlying net income rose 6% to $422 million; U.S. underlying net income rose 32% to USD 141 million; Asia underlying net income rose 8% on a constant-currency basis to $227 million; and Sun Life Asset Management underlying net income rose 6% to USD 297 million. GreenOak gross flows were USD 3.5 billion and net flows were $4 billion, while MFS gross flows were USD 25.5 billion and net outflows were USD 26.9 billion. LICAT ended at 142%, book value per share was $42.79, financial leverage was 24.1%, total CSM was $14.1 billion, and Sun Life returned $780 million to shareholders in the quarter. Forward-looking commentary: management said underlying EPS growth remains in line with the 10% objective, ROE of 19% is within reach of the 20% target, and the dividend payout ratio remains within the 40% to 50% target range. The Board approved a quarterly dividend increase to $1 per common share. Management also said GreenOak’s FRE margin target remains 35% plus and that U.S. disability repricing should take 2 to 3 years to work through renewals.
Kevin Strain framed the quarter as evidence that Sun Life’s diversified model is working, citing growth across Canada, Asia, Stop Loss and GreenOak and saying the firm is executing well on its strategy. He emphasized that higher underlying earnings across all business groups, strong capital, and an industry-leading LICAT ratio give Sun Life flexibility to invest and return capital. His tone was confident but measured, acknowledging U.S. benefits and state dental challenges while highlighting the company’s ability to reprice, reposition, and grow over time.
Tim Deacon focused on the mechanics behind the quarter: underlying net income of $1.146 billion, underlying EPS of $2.05, reported net income of $785 million, and the effects of market-related impacts, GreenOak/Bell integration costs, and a $33 million one-time assumption-review charge. He pointed to a 142% LICAT ratio, 5% book value per share growth to $42.79, 24.1% financial leverage, and $780 million returned to shareholders, including $246 million of buybacks. He also noted that the $1.2 billion Canada Par Block reclassification should have a slightly positive impact on go-forward underlying net income.
Analysts pressed management on the durability of U.S. medical stop-loss strength and whether recent improvement was driven by pricing, volume, or favorable development; management said results were largely driven by pricing actions and higher volume/persistency, with claims in line with expectations. The biggest concern was U.S. disability, where management acknowledged elevated incidence and severity, mostly LTD, with mental health claims broad-based and likely to remain elevated near term; they said repricing takes 2 to 3 years and they are using pricing, expense actions, and case management to respond. Analysts also questioned MFS outflows and expense flexibility, and management said active management headwinds are industry-wide, while MFS will keep investing in areas like ETFs and fixed income rather than cutting costs aggressively if assets fall.
The bull case from this call is that Sun Life is still growing earnings across most businesses despite a tougher environment, with strong contributions from Canada, Asia, Stop Loss and GreenOak. Management sounded confident that capital is strong, the dividend is growing, and medium-term targets for EPS and ROE remain achievable, while GreenOak and U.S. Stop Loss offer long-term upside.
The main risks are persistent U.S. disability pressure, especially elevated LTD incidence and severity, and continued weakness in U.S. dental/Medicaid contracts as the business is repositioned. MFS remains under heavy flow pressure from passive competition and concentrated equity markets, and GreenOak is still in transition with integration and restructuring costs expected to continue into 2027.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 100.0%
- Shares Outstanding
- 554.87M
- Float Shares
- 554.71M
Our SUNFF coverage
Recent articles, reports, and earnings notes.
No research on SUNFF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate SUNFF report →